Researchers at Edinburgh University in the UK have discovered a new approach that leverages mathematical methods devised by Second World War codebreaker Alan Turing for detecting a variety of diseases, including cancer, in advance.

The technique devised to break the Enigma code could be used to help measure the effectiveness of diagnostic tools that are currently in use.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

At present, statistical techniques that were developed in the 1980s are used to evaluate the accuracy of diagnostic tests.

“The technique devised to break the Enigma code could be used to help measure the effectiveness of diagnostic tools that are currently in use.”

They are not capable of measuring the usefulness of a test to determine an individuals’ risk of developing a disease.

Now, researchers at Edinburgh University’s Usher Institute of Population Health Sciences and Informatics believe that the methods devised by Turing could improve these.

Usher Institute of Population Health Sciences and Informatics professor Paul McKeigue told media sources: “Most existing diagnostic tests for identifying people at high risk of cancer or heart disease do not come anywhere near the standards we could hope to see.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“The new era of precision medicine is emerging, and this method should make it easier for researchers and regulatory agencies to decide when a new diagnostic test should be used.”

Alan Turing unveiled the method to break the Enigma code in 1941. His approach investigated the distribution of ‘weights of evidence’ work that establishes the potential outcomes in a given situation to help decide the strategy to crack the code.

The study by Edinburgh University researchers, which is published in Statistical Methods in Medical Research, revealed that applying the same principle is expected to facilitate the development of personalised treatments.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact